# Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial

> **NCT05470816** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Bayside Health** · enrollment: 826 (estimated)

## Conditions studied

- Surgical Site Infection
- Dementia
- Cognition

## Interventions

- **DRUG:** Tranexamic Acid 100Mg/ml Inj Vial 10ml
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05470816
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2026-08-13
- **Final completion:** 2026-08-31
- **Target enrollment:** 826 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470816, "Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05470816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*